Sanofi (NYSE:SNY) gapped down before the market opened on Monday . The stock had previously closed at $37.91, but opened at $38.41. Sanofi shares last traded at $39.18, with a volume of 1,306,000 shares traded.

Several brokerages have commented on SNY. TheStreet lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Monday, August 22nd. Berenberg Bank restated a “hold” rating and set a $93.00 price target on shares of Sanofi in a research note on Monday, August 15th. Zacks Investment Research lowered Sanofi from a “hold” rating to a “sell” rating in a research note on Wednesday, August 3rd. Citigroup Inc. restated a “neutral” rating on shares of Sanofi in a research note on Tuesday, June 28th. Finally, Barclays PLC upgraded Sanofi from an “equal weight” rating to an “overweight” rating in a research note on Thursday, May 12th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $60.50.

The company’s 50-day moving average price is $40.45 and its 200 day moving average price is $40.65. The firm has a market capitalization of $100.85 billion and a PE ratio of 21.64.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.